Elimelech Rosner - Apr 2, 2025 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Signature
/s/ Michael Newton, Attorney-in-Fact
Stock symbol
HQY
Transactions as of
Apr 2, 2025
Transactions value $
-$318,727
Form type
4
Date filed
4/4/2025, 05:30 PM
Previous filing
Jan 10, 2025
Next filing
Apr 10, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Award $0 +16.9K +30.46% $0.00 72.4K Apr 2, 2025 Direct F1
transaction HQY Common Stock Award $0 +117K +161.87% $0.00 190K Apr 2, 2025 Direct F2
transaction HQY Common Stock Tax liability -$319K -3.8K -2% $83.88 186K Apr 3, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2026. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2026.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 117,176 shares on April 2, 2025.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.8740 to $83.8782 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) of this Form 4.

Remarks:

The Power of Attorney given by Mr. Rosner was previously filed with the U.S. Securities and Exchange Commission on July 7, 2023, as an exhibit to a statement on Form 4 filed by Mr. Rosner with respect to HealthEquity, Inc. and is hereby incorporated by reference.